诚达药业
(301201)
| 流通市值：45.53亿 | | | 总市值：64.90亿 |
| 流通股本：1.09亿 | | | 总股本：1.55亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 805,743,567.74 | 818,598,607.96 | 445,496,148.82 | 178,463,170.9 |
| 交易性金融资产 | 177,159,784.4 | 281,962,591.33 | 645,132,195.37 | 957,652,020.32 |
| 应收票据及应收账款 | 105,354,563.27 | 117,590,978.27 | 129,852,780.29 | 94,969,047.08 |
| 其中：应收票据 | 46,917.01 | 2,446,006 | 20,774.75 | 291,272.04 |
| 应收账款 | 105,307,646.26 | 115,144,972.27 | 129,832,005.54 | 94,677,775.04 |
| 应收款项融资 | 3,728,925 | 0 | - | 1,771,823.96 |
| 预付款项 | 10,875,270.41 | 7,939,996.57 | 18,963,808.57 | 3,457,722.4 |
| 其他应收款合计 | 881,992.92 | 534,452.92 | 631,832.92 | 520,028.06 |
| 存货 | 154,088,837.95 | 153,010,511.73 | 127,034,089.95 | 135,271,478.91 |
| 合同资产 | 1,009,275.25 | 1,009,275.25 | 1,009,275.25 | 1,009,275.25 |
| 其他流动资产 | 36,738,944.29 | 38,563,326.35 | 41,037,037.18 | 42,049,089.26 |
| 流动资产合计 | 1,295,581,161.23 | 1,419,209,740.38 | 1,409,157,168.35 | 1,415,163,656.14 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 77,410,000 | 7,410,000 | 7,410,000 | 7,410,000 |
| 投资性房地产 | 45,683,997.78 | 45,969,691.35 | 46,255,384.92 | 46,541,078.49 |
| 固定资产 | 730,604,348.61 | 744,406,607.57 | 761,363,322.57 | 770,793,701.82 |
| 在建工程 | 115,601,483.43 | 79,824,494.04 | 66,164,257.16 | 101,455,413.56 |
| 无形资产 | 35,490,589.91 | 35,890,260.8 | 36,128,816.32 | 36,513,840.37 |
| 长期待摊费用 | 41,278,413.14 | 45,141,531.71 | 40,650,124.91 | 44,118,487.77 |
| 递延所得税资产 | 8,735,916.73 | 8,587,890.8 | 8,378,015.38 | 8,061,540.97 |
| 其他非流动资产 | 18,188,759.81 | 22,218,871.56 | 13,942,218.61 | 6,402,284.96 |
| 非流动资产合计 | 1,072,993,509.41 | 989,449,347.83 | 980,292,139.87 | 1,021,296,347.94 |
| 资产总计 | 2,368,574,670.64 | 2,408,659,088.21 | 2,389,449,308.22 | 2,436,460,004.08 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 157,810,190.81 | 143,981,231.1 | 138,345,655.74 | 189,227,095.01 |
| 其中：应付票据 | 20,388,571.26 | 11,605,156.36 | 15,244,841.2 | 23,265,564.2 |
| 应付账款 | 137,421,619.55 | 132,376,074.74 | 123,100,814.54 | 165,961,530.81 |
| 预收款项 | 84,255.03 | 251,863.02 | 110,106.12 | 16,283 |
| 合同负债 | 2,931,081.25 | 2,140,031.12 | 2,829,944.3 | 2,785,479.67 |
| 应付职工薪酬 | 4,275,382.29 | 4,648,573.43 | 7,133,602.78 | 5,032,448.89 |
| 应交税费 | 5,201,575.45 | 2,716,576.05 | 464,627.73 | 4,767,418.98 |
| 其他应付款合计 | 5,142,236.35 | 4,736,579.74 | 4,332,937.42 | 4,674,483.24 |
| 一年内到期的非流动负债 | 40,738.38 | 61,738.38 | - | 62,314.29 |
| 其他流动负债 | - | - | - | 194,136.62 |
| 流动负债合计 | 175,485,459.56 | 158,536,592.84 | 153,216,874.09 | 206,759,659.7 |
| 非流动负债: | | | | |
| 长期借款 | 58,197,679.9 | 88,197,679.9 | 88,197,679.9 | 80,118,379.9 |
| 递延收益 | 1,915,532.12 | 2,114,075.3 | 2,312,618.48 | 2,511,161.66 |
| 递延所得税负债 | 783,187.91 | 1,121,624.86 | 1,361,133.46 | 1,377,218.92 |
| 非流动负债合计 | 60,896,399.93 | 91,433,380.06 | 91,871,431.84 | 84,006,760.48 |
| 负债合计 | 236,381,859.49 | 249,969,972.9 | 245,088,305.93 | 290,766,420.18 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 154,713,824 | 154,713,824 | 154,713,824 | 154,713,824 |
| 资本公积 | 1,693,936,183.68 | 1,693,936,183.68 | 1,693,936,183.68 | 1,693,936,183.68 |
| 减:库存股 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 | 57,073,347.67 |
| 其他综合收益 | -19,201,500 | -19,201,500 | -19,201,500 | -19,201,500 |
| 盈余公积 | 58,491,579.28 | 58,491,579.28 | 58,491,579.28 | 58,491,579.28 |
| 未分配利润 | 298,663,667.51 | 325,008,542.44 | 310,784,184.13 | 312,184,166.11 |
| 归属于母公司股东权益合计 | 2,129,530,406.8 | 2,155,875,281.73 | 2,141,650,923.42 | 2,143,050,905.4 |
| 少数股东权益 | 2,662,404.35 | 2,813,833.58 | 2,710,078.87 | 2,642,678.5 |
| 股东权益合计 | 2,132,192,811.15 | 2,158,689,115.31 | 2,144,361,002.29 | 2,145,693,583.9 |
| 负债和股东权益合计 | 2,368,574,670.64 | 2,408,659,088.21 | 2,389,449,308.22 | 2,436,460,004.08 |
| 公告日期 | 2025-10-28 | 2025-08-26 | 2025-04-25 | 2025-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |